Ozone has been proposed for water disinfection because it is more efficient than chlorine for killing microbes and results in much lower levels of carcinogenic trihalomethanes than does chlorination. Ozone leads to formation of hypobromous acid in surface waters with high bromine content and forms brominated organic by-products and bromate. The carcinogenicity and chronic toxicity of potassium bromate (KBrO3) was studied in male B6C3F1 mice and F344/N rats to confirm and extend the results of previous work. Mice were treated with 0, 0.08, 0.4, or 0.8 g/L KBrO3 in the drinking water for up to 100 wk, and rats were provided with 0, 0.02, 0.1, 0.2, or 0.4 g/L KBr03. Animals were euthanatized, necropsied, and subjected to a complete macroscopic examination. Selected tissues and gross lesions were processed by routine methods for light microscopic examination. The present study showed that KBr03is carcinogenic in the rat kidney, thyroid, and mesothelium and is a renal carcinogen in the male mouse. KBr03 was carcinogenic in rodents at water concentrations as low as 0.02 g/L (20 ppm; 1.5 mg/kg/day). These data can be used to estimate the human health risk that would be associated with changing from chlorination to ozonation for disinfection of drinking water.
4. Anonymous (1994). Final report on the safety assessment of sodium bromate and potassium bromate. J. Am. Coll. Toxicol.. 13: 400–414.
5.
5. Anonymous (1996). Safe Drinking Water Act Amendments of 1996. Public Law 104-182.
6.
6. Bull RJ and Kopfler FC (1991). Health Effects of Disinfectants and Disinfection By-products.American Water Works Association Research Foundation, Denver.
7.
7. Bull RJ, Sanchez IM, Nelson MA, Larson JL, and Lansing AJ (1990). Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63: 341–359.
8.
8. Carlton WW and Englehardt JA (1986). Chloroform nephrosis, male mouse. In: Urinary System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin, pp. 225–228.
9.
9. Carmichael NG, Winder C, Borges SH, Backhouse BL, and Lewis PD (1982). The health implications of water treatment with ozone. Life Sci.. 30: 117–129.
10.
10. Cavanagh JE, Weinberg HS, Gold A, Sangalah R, Marbury D, Glase WH, Collette TW, Richardson SD, and Thruston AD (1992). Ozonation byproducts: Identification of bromohydrins from the ozonation of natural waters with enhanced bromide levels. Environ. Sci. Technol.. 26: 1658–1662.
11.
11. De Vriese A, Vanholder R, and Lameire N (1997). Severe acute renal failure due to bromate intoxication: Report of a case and discussion of management guidelines based on a review of the literature. Nephrol. Dial. Transplant.. 12: 204–209.
12.
12. Dunn TB (1948). Sex differences in the alkaline phosphatase distribution in the kidney of the mouse. Am. J. Pathol.. 24: 719–720.
13.
13. Dunnick JK, Eustis SL, and Lilja HS (1987). Bromodichloromethane, a trihalomethane that produces neoplasms in rodents. Cancer Res.. 47: 5189–5193.
14.
14. Environmental Protection Agency (1996). Reprints of EPA Methods for Chemical Analyses under the Information Collection Rule.Technical Report No. 814-B-96-006, Office of Groundwater and Drinking Water's Technical Support Division, Cincinnati, Ohio.
15.
15. Fienberg SW (1980). The Analysis of Cross-Classified Data. MIT Press, Cambridge, Massachusetts.
16.
16. Fiessinger F, Rook JJ, and Duguet JP (1985). Alternative methods for chlorination. Sci. Total Environ.. 47: 299–315.
17.
17. Fisher N, Hutchinson JB, Berry R, Hardy J, Ginocchio AV, and Waite V (1979). Long-term toxicity and carcinogenicity studies of the bread improver potassium bromate. 1. Studies in rats. Food Cosmet. Toxicol.. 17: 33–39.
18.
18. Glaze WH (1986). Reaction products of ozone: A review. Environ. Health Perspect.69: 151–157
19.
19. Ginocchio AV, Waite V, Hardy J, Fisher N, Hutchinson JB, and Berry R (1979). Long-term toxicity and carcinogenicity studies of the bread improver potassium bromate. 2. Studies in mice. Food Cosmet. Toxicol.. 17: 41-–47.
20.
20. Hall WC (1990). Peritoneum, retroperitoneum, mesentery, and abdominal cavity. In: Pathology of the Fischer Rat, GA Boorman, SL Eustis, MR Elwell, CA Montgomery, and WF MacKenzie (eds). Academic Press, San Diego, pp. 63–69.
21.
21. Hardisty JF and Boorman GA (1990). Thyroid gland. In: Pathology of the Fischer Rat, GA Boorman, SL Eustis, MR Elwell, CA Montgomery, and WF MacKenzie (eds). Academic Press, San Diego, pp. 519–534.
22.
22. Ishidate M, Sofuni T, Yoshikawa K, Hayashi M, Nohmi T, Sawada M, and Matsuoka A (1984). Primary mutagenicity screening of food additives currently used in Japan. Food Chem. Toxicol.. 22: 623–636.
23.
23. Jorgenson TA, Meierhenry EF, Rushbrook CJ, Bull RJ, and Robinson M (1985). Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl Toxicol.. 5: 760–769.
24.
24. Koenig H, Goldstone A, Blume G, and Lu C (1980). Testosterone-mediated sexual dimorphism of mitochondria and lysosomes in mouse kidney proximal tubules. Science209: 1023–1026
25.
25. Krasner SW, McGuire MJ, Jacagnelo JG, Patania NL, Reagan KM, and Aieta EM (1989). The occurrence of disinfection by-products in U.S. drinking water. J. Am. Wafer Works Assoc.. 81: 41–43.
26.
26. Kurata Y, Diwan BA, and Ward JM (1992). Lack of renal tumour-initiating activity of a single dose of postassium bromate, a geno-toxic renal carcinogen in male F344/NCr rats. Food Chem. Toxicol.. 30: 251–259.
27.
27. Kurokawa Y, Aoki S, Matsushima Y, Takamura N, Imazawa T, and Hayashi Y (1986). Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. J. Natl. Cancer Inst.. 77: 977–982.
28.
28. Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, and Kokubo T (1982). Induction of renal cell tumors in F-344 rats by oral administration of potassium bromate, a food additive. Gann. 73: 335–338.
29.
29. Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T, and Odashima S (1983). Carcinogenicity of potassium bromate administered orally to F344 rats. J. Natl. Cancer Inst.. 71: 965–972.
30.
30. Kurokawa Y, Maekawa A, Takahashi M, and Hayashi Y (1990). Toxicity and carcinogenicity of potassium bromate–A new renal carcinogen. Environ. Health Perspect.. 87: 309–335.
31.
31. Kurokawa Y, Matsushima Y, Takamure N, Imazawa T, and Hayashi Y (1987). Relationship between the duration of treatment and the incidence of renal cell tumors in male F344 rats administered potassium bromate. Jpn. J. Cancer Res.. 78: 358–364.
32.
32. Kurokawa Y, Takayama S, Konishi Y, Hiasa Y, Asahina S, Takahashi M, Maekawa A, and Hayashi Y (1986). Long-term in vivo carcinogenicity tests of potassium bromate, sodium hypochlorite, and sodium chlorite conducted in Japan. Environ. Health Perspect.. 69: 221–235.
33.
33. Kurokawa Y, Takamura N, Matsuoka C, Imazawa T, Matsushima Y, Onodera H, and Hayashi Y (1987). Comparative studies on lipid peroxidation in the kidney of rats, mice, and hamsters and on the effect of cysteine, glutathione, and diethyl maleate treatment on mortality and nephrotoxicity after administration of potassium bromate. J. Am. Coll. Toxicol.. 6: 489–501.
34.
34. Kurokawa Y, Takamura N, Matsushima Y, Imazawa T, and Hayashi Y (1984). Studies on the promoting and complete carcinogenic activites of some oxidizing chemicals in skin carcinogenesis. Cancer Lett.. 24: 299–304.
35.
35. Lawrence J and Cappelli FP (1977). Ozone in drinking water treatment: A review. Sci. Total Environ.. 7: 99–108.
36.
36. Lee YS, Choi JY, Park MK, Choi EM, Kasai H, and Chung MH (1996). Induction of OH8Gua glycosylase in rat kidneys by potassium bromate (KBrO3), a renal oxidative carcinogen. Mutat. Res.. 364: 227–233.
37.
37. Liebelt AG (1986). Unique features of anatomy, histology and ultrastructure, kidney, mouse. In: Urinary System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin, pp. 24–44.
38.
38. Matsushima Y, Takamura N, Imazawa T, Kurokawa Y, and Hayashi Y (1986). Lack of carcinogenicity of potassium bromate after subcutaneous injection of newborn mice and newborn rats. Sci. Rep. Res. Inst. Tohoku Univ.. 33: 22–26.
39.
39. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, and Milner A (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci.. 84: 407–412.
40.
40. Montgomery CA and Seely JC (1990). Kidney. In: Pathology of the Fischer Rat.GA Boorman, SL Eustis, MR Elwell, CA Montgomery, and WF MacKenzie (eds). Academic Press, San Diego, pp. 140–142.
41.
41. National Institute for Environmental Health Sciences (1996). Tumor Incidence in Control Animals by Route and Vehicle of Administration: B6C3F1 Mice.Analytical Science, Durham, North Carolina.
42.
42. National Institute for Environmental Health Sciences (1996). Tumor Incidence in Control Animals by Route and Vehicle of Administration: F344/N Rats.Analytical Science, Durham, North Carolina.
43.
43. Niwa T, Ito T, and Matsui E (1974). Serial renal biopsy in potassium bromate intoxication. Jpn. Circ. J.38: 387–392
44.
44. Ohno Y, Onodera H, Takamura N, Imazawa T, Maekawa A, and Kurokawa Y (1982). Carcinogenicity of potassium bromate in F-344 rats. Eisei Shikenjo Hokoku. 100: 93–100.
45.
45. Robeck GC (1981). Chlorine, is that a better alternative? Sci. Total Environ.. 18: 235–243.
46.
46. Sai K, Takagi A, Umemura T, Hasegawa R, and Kurokawa Y (1991). Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate. Jpn. J. Cancer Res.. 82: 165–169.
47.
47. Sai K, Uchiyama S, Ohno Y, Hasegawa R, and Kurokawa Y (1992). Generation of active oxygen species in vitro by the interaction of potassium bromate with rat kidney cell. Carcinogenesis. 13: 333–339.
48.
48. Sai K, Umemura T, Takagi A, Hasegawa R, and Kurokawa Y (1992). The protective role of glutathione, cysteine and vitamin C against oxidative DNA damage induced in rat kidney by potassium bromate. Jpn. J. Cancer Res.. 83: 45–51.
49.
49. Takamura N, Kurokawa Y, Matsushima Y, Imazawa T, Onodera H, and Hayashi Y (1985). Long-term oral administration of potassium bromate in male Syrian golden hamsters. Sci. Rep. Res. Inst. Tohoku Univ. Ser. C Med.. 32: 43–46.
50.
50. Tarone RE and Ware J (1977). On distribution-free tests for equality of survival distributions. Biometrika. 64: 156–169.
51.
51. Thomas GA and Williams D (1994). Changes in structure and function of the thyroid follicular cell. In: Patholobiology of the Aging Rat. Vol. 2, U Mohr, DL Dungworth, and CC Capen (eds). ILSI Press, Washington, D.C., pp. 277–280.
52.
52. Umemura T, Sai K, Takagi A, Hasegawa R, and Kurokawa Y (1995). A possible role for oxidative stress in potassium bromate (KBrO3) carcinogenesis. Carcinogenesis. 16: 593–597.
53.
53. Winer B (1971). Statistical Principles in Experimental Design.McGraw-Hill, New York, pp. 337–347.
54.
54. Wolf DC, and Carlton WW (1990). Acute cortical tubular necrosis in the Swiss ICR mouse induced by 2-bromoethyIamine hydro-bromide. Food Chem, Toxicol.. 28: 351–360.
55.
55. Wolf DC, Carlton WW, and Turek JJ (1992). Experimental renal papillary necrosis in the Mongolian gerbil. Toxicol. Pathol.. 20: 150–172.
